A multicenter prospective study to assess the impact of physician's reinforcement on the subject's compliance and persistence on treatment using feedback on bone markers in previously undiagnosed postmenopausal osteoporotic women treated with risedronate [risedronic acid].

Trial Profile

A multicenter prospective study to assess the impact of physician's reinforcement on the subject's compliance and persistence on treatment using feedback on bone markers in previously undiagnosed postmenopausal osteoporotic women treated with risedronate [risedronic acid].

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Sep 2006

At a glance

  • Drugs Risedronic acid (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Acronyms IMPACT
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 14 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top